Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Morphological changes in prolactinoma induced by bromocriptine treatment].

M Scanarini1

  • 1Divisione di Neurochirurgia, Complesso Convenzionato, Ospedale-Università di Padova.

Minerva Endocrinologica
|January 1, 1990
PubMed
Summary

Bromocriptine treatment softens prolactin-secreting pituitary adenomas, aiding surgery. However, long-term use causes fibrosis, making tumors harder to remove.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.

Journal of neuroendocrinology·2011
Same author

Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulation.

European psychiatry : the journal of the Association of European Psychiatrists·2010
Same author

Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.

Journal of neuroendocrinology·2007
Same author

The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.

European journal of endocrinology·2007
Same author

First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.

Journal of endocrinological investigation·2007
Same author

Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2006

Area of Science:

  • Endocrinology
  • Neurosurgery
  • Oncology